PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 3 filers reported holding PRECIGEN INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,505,938 | +19.3% | 1,060,520 | -3.4% | 0.00% | – |
| Q2 2023 | $1,262,331 | +15.1% | 1,097,679 | +6.1% | 0.00% | – |
| Q1 2023 | $1,096,674 | -4.7% | 1,034,598 | +36.6% | 0.00% | – |
| Q4 2022 | $1,151,297 | -27.3% | 757,432 | +1.5% | 0.00% | -100.0% |
| Q3 2022 | $1,583,000 | +76.5% | 746,525 | +11.6% | 0.00% | – |
| Q2 2022 | $897,000 | -41.2% | 668,824 | -7.5% | 0.00% | – |
| Q1 2022 | $1,526,000 | -45.4% | 723,138 | -4.1% | 0.00% | -100.0% |
| Q4 2021 | $2,797,000 | -24.1% | 753,705 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $3,685,000 | -22.2% | 738,344 | +1.7% | 0.00% | -50.0% |
| Q2 2021 | $4,734,000 | +17.8% | 725,930 | +24.4% | 0.00% | +100.0% |
| Q1 2021 | $4,020,000 | -15.7% | 583,343 | +24.8% | 0.00% | -50.0% |
| Q4 2020 | $4,768,000 | +200.6% | 467,411 | +3.2% | 0.00% | +100.0% |
| Q3 2020 | $1,586,000 | -29.7% | 452,874 | +0.2% | 0.00% | 0.0% |
| Q2 2020 | $2,257,000 | +48.4% | 452,123 | +1.1% | 0.00% | 0.0% |
| Q1 2020 | $1,521,000 | – | 447,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 11,243,560 | $12,930,093 | 0.72% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 3,333,468 | $3,833,488 | 0.36% |
| First Washington CORP | 592,975 | $681,921 | 0.30% |
| Fore Capital, LLC | 490,000 | $563,500 | 0.26% |
| EMFO, LLC | 180,000 | $207,000 | 0.19% |
| MSD Partners, L.P. | 960,000 | $1,104,000 | 0.10% |
| SANDERS MORRIS HARRIS LLC | 325,000 | $373,750 | 0.08% |
| Virtus ETF Advisers LLC | 87,692 | $100,846 | 0.06% |
| XTX Topco Ltd | 263,046 | $302,503 | 0.05% |
| CHIRON CAPITAL MANAGEMENT, LLC | 45,906 | $52,792 | 0.04% |